CANCER THERAPY WITH CO-DELIVERY OF CAMPTOTHECIN
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 3
Abstract
This essay has discussed various ways by which two or more than two drugs have been combined with Camptothecin through nanoparticles in order to yield anti-cancer therapy effectiveness. A systematic and comprehensive literature review has been prepared to show such combinations demonstrated high anticancer efficacy.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP295538
- DOI 10.22270/jddt.v7i3.1450
- Views 77
- Downloads 0
FORMULATION AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEMS OF GLIPIZIDE FOR THE MANAGEMENT OF TYPE-II DIABETES MELLITUS
The objective of the present study was to fabricate and evaluate a chronomodulated pulsatile drug delivery system to maintain the blood glucose level by releasing the drug at a predetermined time interval. The basic desi...
PHYTOCHEMICAL EVALUATION OF MONOCOT GRASS KYLLINGA TRICEPS ROTTB.
Kyllinga triceps rottb. A monocot perennial herb found in various parts of India is traditionally used in vitiated conditions pitta and vata, hyperdipsia, fever, liver disorders, verminosis, cough, splenopathy, diabetes...
IN-VIVO ANTIOXIDANT EFFECT OF ABROMA AUGUSTA IN DIABETES INDUCED OXIDATIVE STRESS
The present study was aimed to investigate the In-vivo antioxidant activity of roots of Abroma augusta in streptozotocin-nicotinamide induced Type-II diabetes. The extraction (Hot continuous extraction process) was carri...
A REVIEW ON FAST DISSOLVING TABLET
The convenience of administration and improved patient compliance are important in the design of oral drug delivery system which remains the preferred route of drug delivery inspite of various disadvantages. Fast disinte...
PREPARATION, CHARACTERIZATION AND EVALUATION OF NEBIVOLOL LOADED CHITOSAN NANOPARTICLES
Nebivolol (NEB) is an antihypertensive drug with poor oral bioavailability (12%) in humans due to extensive first pass hepatic metabolism. Present work is an attempt to improve oral bioavailability of nebivolol by incorp...